NABULSI AZMI (Chief Operating Officer) sold 4.3% of their position (10.90K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $127.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/17/2024ACC: 0000950170-24-084186
Officer· Chief Operating Officer
Since Oct 2019
-10.90K
Net shares
Net seller
$127.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.90K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.90K
Price / share
$11.72
Trade value
$127.76K
% of position
4.3%
7/15/2024
251.32K→240.42K
Total
Net shares
−10.90K
Net value
-$127.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/15/2024 | S · Sale | −10.90K | $11.72 | $127.76K | 4.3% | 251.32K | 240.42K |
| Total | −10.90K | -$127.76K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned785.70K
Common Stock
IndirectShares owned3.58K
Total
789.28K indirect789.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 785.70K | Indirect |
| Common Stock | 3.58K | Indirect |
| Total | 789.28K | 789.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported